Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Therapy for Prevention of NODAT
NCT03507829Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2012
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, open-label trial of insulin isophane and insulin lispro in diabetes mellitus (DM), sponsored by Medical University of Vienna. Primary endpoint: Incidence of New-Onset Diabetes After Transplantation at 12 months. Started Nov 2012; status: completed.
02
Drugs
insulin isophaneinsulin lispro
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT03507829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03507829.